CVH-Dr Sholar

Dr. Lima, in full PPE, has added a photograph of herself to the front of her gown to help patients easily identify who she is.

Our current positivity rate over the past 30 days is 27.2 percent. Clearwater County is averaging 19 new cases per day and the rate is 217 per 100,000 people. On several days recently Clearwater County has been the county with the highest per-capita rate in Idaho.

COVID is the leading cause of death in November 2020 for Idahoans.

COVID is the third leading cause of death in Idahoans thus far in 2020.

Idaho has more cases than Oregon. Oregon has 2.4 times the population of Idaho.

At CVH we do have a small supply of the monoclonal antibody infusion, bamlanivimab, that can be offered to some high risk patients in the first days of their illness. This has minimal benefit, and is not helpful in patients who are sick enough to be hospitalized. It is a 1 hour infusion. We also have supplies of remdesivir and dexamethasone for our ill patients that may benefit from these medications.

However, there is no cure for COVID-19 disease and the medications that are available have marginal benefit at most.

CVH is getting our first shipment of a COVID vaccine this week, in a limited supply.

Please continue to do your part in helping to slow the spread of COVID-19. Wear masks when around people who are not in your household, practice social distancing and good hand hygiene and avoid gatherings of more than 10 people.

(1) comment

rmchavin

Here are clinical trials in which remdesivir failed to shorten hospital stays or reduce deaths:

https://www.medrxiv.org/content/10.1101/2020.10.15.20209817v1

https://pubmed.ncbi.nlm.nih.gov/33264556/

https://www.nejm.org/na101/home/literatum/publisher/mms/journals/content/nejm/0/nejm.ahead-of-print/nejmoa2023184/20201202/images/img_medium/nejmoa2023184_f2.jpeg

https://www.nejm.org/na101/home/literatum/publisher/mms/journals/content/nejm/0/nejm.ahead-of-print/nejmoa2023184/20201202/images/img_medium/nejmoa2023184_f3.jpeg

https://rebelem.com/remdesivir-in-moderate-covid-19/

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7190303/

The researchers who completed the 1,643-participant, New York City remdesivir clinical trial imply that in the ACTT-1 clinical trial, the sicker patients must have been sneaked into the placebo group to get the rigged result that got remdesivir approved:

https://www.medrxiv.org/content/10.1101/2020.08.10.20171637v1

https://link.springer.com/article/10.1007/s41669-020-00243-6

Remdesivir is totally useless against all viral diseases, including the flu, common cold, and Ebola:

https://www.nejm.org/doi/full/10.1056/NEJMoa1910993

https://www.nejm.org/na101/home/literatum/publisher/mms/journals/content/nejm/2019/nejm_2019.381.issue-24/nejmoa1910993/20191206/images/img_xlarge/nejmoa1910993_f1.jpeg

Remdesivir is fraudulently indicated for end-stage COVID-19 when in truth, it has absolutely no benefit in reducing the cytokine storm, in fact, might make it slightly worse:

https://www.nature.com/articles/s41591-020-1051-9

https://www.nature.com/articles/s41591-020-1051-9/figures/5

https://www.mdpi.com/tropicalmed/tropicalmed-05-00112/article_deploy/html/images/tropicalmed-05-00112-g004.png

https://finance.yahoo.com/chart/GILD

Remdesivir, hydroxychloroquine, and chloroquine cause cardiovascular QT interval prolongation and sinus bradycardia:

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7571425/

https://www.sciencedirect.com/science/article/abs/pii/S0022073620305835

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7598346/

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7682945/

Remdesivir causes liver damage:

https://theprint.in/health/govt-reviewing-remdesivir-use-for-covid-after-hospitals-report-liver-damage-in-patients/454169/

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7381904/

https://pubmed.ncbi.nlm.nih.gov/33006138/

Remdesivir causes kidney damage:

https://www.rxlist.com/consumer_remdesivir_rdv/drugs-condition.htm

https://pubmed.ncbi.nlm.nih.gov/33252992/

Remdesivir, Kaletra, and ribavirin worsen the skin rash problem during COVID-19:

https://pubmed.ncbi.nlm.nih.gov/33301232/

In Europe, ESICM now advises against remdesivir:

https://wkzo.com/2020/11/13/worlds-top-intensive-care-body-advises-against-remdesivir-for-sickest-covid-patients/

Welcome to the discussion.

Keep it Clean. Please avoid obscene, vulgar, lewd, racist or sexually-oriented language.
PLEASE TURN OFF YOUR CAPS LOCK.
Don't Threaten. Threats of harming another person will not be tolerated.
Be Truthful. Don't knowingly lie about anyone or anything.
Be Nice. No racism, sexism or any sort of -ism that is degrading to another person.
Be Proactive. Use the 'Report' link on each comment to let us know of abusive posts.
Share with Us. We'd love to hear eyewitness accounts, the history behind an article.